FINWIRES · TerminalLIVE
FINWIRES

研究速報:LSCC:AIサーバーの強さが総合的な勝利を牽引。新たな契約が発表されました。

By

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。LSCCは第1四半期に過去最高の売上高1億7,090万ドル(前年同期比+42.2%、前期比+17.2%)を記録し、ガイダンスレンジの1億5,800万ドル~1億7,200万ドル、市場コンセンサス予想の1億6,500万ドルを大きく上回りました。非GAAPベースの1株当たり利益(EPS)は0.41ドル(前年同期比+86%)となり、予想の0.37ドルを上回りました。これは、コンピューティングおよび通信事業の好調(86%増の1億660万ドル)と、加速する産業部門の回復(前期比+21%の6,430万ドル)によるものです。同社は、完全なセキュア管理プラットフォームを構築し、サービス対象市場を倍増させ、年間売上高10億ドル超への軌道を支えるため、AMIを16億5000万ドルで戦略的に買収すると発表した(現金10億ドル、株式6億5000万ドル)。第2四半期の売上高ガイダンスは1億7500万ドル~1億9500万ドル、EPSは0.42ドル~0.46ドルだったが、いずれも予想を上回り、それぞれ1億7100万ドルと0.38ドルとなった。チャネル在庫の正常化はほぼ完了しており、AIデータセンターの需要により、コンピューティング部門が総売上高の62%を占めている。利益率は改善し、非GAAP粗利益率は70.0%、EBITDAマージンは39.6%となり、当社の予想をわずかに上回り、事業規模の拡大に伴い、営業レバレッジが大幅に向上していることが示された。

Related Articles

Research

Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Aptargroup, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month target at $149, 26.8x our 2026 EPS estimate, a premium to its three-year average forward P/E of 26.5x. We trim our 2026 EPS view by $0.12 to $5.56 and decrease our 2027 EPS by $0.15 to $6.40. The injectables division continues to validate our thesis, with 20% Y/Y growth in Q1 as management actively works to increase capacity so the division can expand further. We note that emergency medicine faces a $65M headwind in 1H 2026 as it destocks from prior inventory, which led to flat Q1 core sales and weaker gross margins. Management is confident its pharma growth will expand beyond GLP-1 to both systemic nasal drug delivery and pulmonary biologics. Margin weakness and an unfavorable mix in the Beauty segment are temporary, with normal margins returning in 2H 2026 in our view. We continue to believe ATR is poised to capture significant growth in the biologics markets. ATR could face higher raw material costs as supply chains become stretched due to uncertainty in the Middle East.

$ATR
Asia

Lottery Secures Agreement for 40-Year License Extension

Lottery (ASX:TLC) secured an agreement with the Victorian State Government for a 40-year extension of the public lottery license, according to a Tuesday filing with the Australian bourse.The license is extended to June 30, 2068, with the company paying an upfront premium of AU$1.15 billion to the state, the filing said.Historically, the license has been offered on 10-year terms and was set to expire on June 30, 2028, per the filing.

$ASX:TLC
Asia

Gentrack Group Cuts Fiscal 2026 Revenue Guidance; Plans Buyback; Kiwi Shares Fall 22%

Gentrack Group (NZE:GTK, ASX:GTK) said it now expects fiscal year 2026 revenue of between NZ$229 million and NZ$238 million, lower than its previous guidance, according to a Tuesday filing with the Australian and New Zealand bourses.The company expects fiscal year 2026 recurring revenue to grow by over 10% to around NZ$174 million. It also expects fiscal first-half revenue of around NZ$110 million, of which roughly NZ$85 million would be recurring, per the filing.Gentrack said it expects fiscal year 2026 earnings before interest, taxes, depreciation, and amortization (EBITDA) of NZ$13.5 million to NZ$20 million, and fiscal first half EBITDA of about NZ$7.8 million, both excluding acquisition costs.The guidance comes as the company has decided "to prioritize growth and global leadership over short-term EBITDA" and continues to invest in international expansion and product development, it said.The company maintained its medium-term target of a more than 15% compound annual growth rate for revenue.Additionally, after the release of fiscal first-half results, Gentrack's board plans to launch an on-market share buyback for up to 5% of the company's issued shares, per the filing.The company's Kiwi shares fell 22% in recent Tuesday trade on the New Zealand bourse.

$ASX:GTK$NZE:GTK